Effectdossier · gearchiveerd kwartaal
CTKB
Cytek Biosciences, Inc. · Healthcare · Medical - Devices
19Gevolgde houders
+4Δ houders
43.35MGehouden aandelen
$150.42MGerapporteerde waarde
+4Nieuwe posities
−0Uitstappen
Momentum-inputs (vergelijkbare managers):
breedte van houders +26.7% ·
aandelenstroom +8.0% ·
netto nieuwe posities +20.0%
— formule
Brede accumulatie — stijgende aandelen bij meer houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q3 2025
Eigendom in de tijd
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 74 | 0 | 60.52M | $268.04M | +6 | −6 |
| Q1 2026 | 76 | +1 | 60.92M | $266.22M | +4 | −3 |
| Q4 2025 | 75 | -1 | 61.04M | $308.28M | — | −1 |
| Q3 2025 | 19 | +4 | 43.35M | $150.42M | +4 | — |
| Q2 2025 | 12 | 0 | 36.22M | $123.14M | +1 | −1 |
| Q1 2025 | 9 | 0 | 9.63M | $38.61M | +1 | −1 |
| Q4 2024 | 9 | +1 | 10.70M | $69.47M | +1 | — |
| Q3 2024 | 7 | 0 | 5.47M | $30.29M | — | — |
| Q2 2024 | 7 | — | 6.05M | $33.76M | — | — |
Wie het bezit · Q3 2025
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (passief) | 16.55M | -2.9% | $57.42M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 2 | BlackRock ✦ (passief) | 16.55M | -2.9% | $57.42M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 3 | BlackRock ✦ (passief) | 16.55M | -2.9% | $57.42M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 4 | BlackRock ✦ (passief) | 16.55M | -2.9% | $57.42M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 5 | BlackRock ✦ (passief) | 16.55M | -2.9% | $57.42M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 6 | BlackRock ✦ (passief) | 16.55M | -2.9% | $57.42M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 7 | BlackRock ✦ (passief) | 16.55M | -2.9% | $57.42M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 8 | BlackRock ✦ (passief) | 16.55M | -2.9% | $57.42M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 9 | The Vanguard Group ✦ (passief) | 6.93M | -10.7% | $24.06M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 10 | The Vanguard Group ✦ (passief) | 6.93M | -10.7% | $24.06M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 11 | The Vanguard Group ✦ (passief) | 6.93M | -10.7% | $24.06M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 12 | State Street Global Advisors ✦ (passief) | 4.08M | -2.1% | $14.17M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 13 | Millennium Management ✦ | 3.42M | +269.6% | $11.86M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 14 | Geode Capital Management ✦ (passief) | 2.78M | +2.0% | $9.66M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 15 | Geode Capital Management ✦ (passief) | 2.78M | +2.0% | $9.66M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 16 | Wellington Management ✦ | 2.54M | Nieuw | $8.82M | 0.0% | New | 1 | SEC ↗ |
| 17 | Wellington Management ✦ | 2.54M | Nieuw | $8.82M | 0.0% | New | 1 | SEC ↗ |
| 18 | Wellington Management ✦ | 2.54M | Nieuw | $8.82M | 0.0% | New | 1 | SEC ↗ |
| 19 | Wellington Management ✦ | 2.54M | Nieuw | $8.82M | 0.0% | New | 1 | SEC ↗ |
| 20 | Goldman Sachs Group ✦ | 1.74M | — | $6.03M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | Goldman Sachs Group ✦ | 1.74M | — | $6.03M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | Goldman Sachs Group ✦ | 1.74M | — | $6.03M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | Morgan Stanley ✦ | 1.46M | — | $5.08M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | Morgan Stanley ✦ | 1.46M | — | $5.08M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | Morgan Stanley ✦ | 1.46M | — | $5.08M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | Morgan Stanley ✦ | 1.46M | — | $5.08M | 0.0% | n/c | 1 | SEC ↗ |
| 27 | Morgan Stanley ✦ | 1.46M | — | $5.08M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | Morgan Stanley ✦ | 1.46M | — | $5.08M | 0.0% | n/c | 1 | SEC ↗ |
| 29 | Morgan Stanley ✦ | 1.46M | — | $5.08M | 0.0% | n/c | 1 | SEC ↗ |
| 30 | Morgan Stanley ✦ | 1.46M | — | $5.08M | 0.0% | n/c | 1 | SEC ↗ |
| 31 | AQR Capital Management ✦ | 1.02M | -17.6% | $3.54M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 32 | AQR Capital Management ✦ | 1.02M | -17.6% | $3.54M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 33 | AQR Capital Management ✦ | 1.02M | -17.6% | $3.54M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 34 | AQR Capital Management ✦ | 1.02M | -17.6% | $3.54M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 35 | AQR Capital Management ✦ | 1.02M | -17.6% | $3.54M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 36 | Renaissance Technologies ✦ | 795.54K | -25.2% | $2.76M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 37 | JPMorgan Chase ✦ | 717.45K | — | $2.49M | 0.0% | n/c | 1 | SEC ↗ |
| 38 | JPMorgan Chase ✦ | 717.45K | — | $2.49M | 0.0% | n/c | 1 | SEC ↗ |
| 39 | JPMorgan Chase ✦ | 717.45K | — | $2.49M | 0.0% | n/c | 1 | SEC ↗ |
| 40 | JPMorgan Chase ✦ | 717.45K | — | $2.49M | 0.0% | n/c | 1 | SEC ↗ |
| 41 | JPMorgan Chase ✦ | 717.45K | — | $2.49M | 0.0% | n/c | 1 | SEC ↗ |
| 42 | JPMorgan Chase ✦ | 717.45K | — | $2.49M | 0.0% | n/c | 1 | SEC ↗ |
| 43 | JPMorgan Chase ✦ | 717.45K | — | $2.49M | 0.0% | n/c | 1 | SEC ↗ |
| 44 | JPMorgan Chase ✦ | 717.45K | — | $2.49M | 0.0% | n/c | 1 | SEC ↗ |
| 45 | Arrowstreet Capital ✦ | 361.29K | +150.5% | $1.25M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 46 | Point72 Asset Management ✦ | 187.62K | Nieuw | $651,033 | 0.0% | New | 1 | SEC ↗ |
| 47 | Fidelity (FMR) ✦ | 180.79K | -12.1% | $627,327 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 48 | Two Sigma Investments ✦ | 175.76K | Nieuw | $609,884 | 0.0% | New | 1 | SEC ↗ |
| 49 | Marshall Wace ✦ | 134.29K | -48.6% | $465,975 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 50 | Marshall Wace ✦ | 134.29K | -48.6% | $465,975 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 51 | D. E. Shaw & Co. ✦ | 121.02K | Nieuw | $419,946 | 0.0% | New | 1 | SEC ↗ |
| 52 | Citadel Advisors ✦ | 82.30K | -86.7% | $285,595 | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 53 | T. Rowe Price ✦ | 62.13K | +9.3% | $216,000 | 0.0% | ▲ Add | 6 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Wellington Management | $8.82M | 0.0% |
| Wellington Management | $8.82M | 0.0% |
| Wellington Management | $8.82M | 0.0% |
| Wellington Management | $8.82M | 0.0% |
| Point72 Asset Management | $651,033 | 0.0% |
| Two Sigma Investments | $609,884 | 0.0% |
| D. E. Shaw & Co. | $419,946 | 0.0% |
Verlaten
| Geen bijgehouden uitstappen dit kwartaal. |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 164 houders, 84.77M aandelen, $364.62M gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Vaak gezamenlijk in bezit
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.
Aug 06
SC 13G/A — MILLENNIUM MANAGEMENT LLC
Aug 04
SC 13G — Boston Partners
Jul 08
SC 13G/A — BlackRock, Inc.
Herkomst: Eigendom op basis van geparseerde 13F common-stockposities (gevolgde universum, vergelijkbare sets voor wijzigingen); insider-rijen afkomstig van formulieren 3/4/5; belangen uit Schedules 13D/13G; elke indiening verwijst naar het origineel op SEC EDGAR.
Rapportageperiode: Q3 2025 ·
Methodologie ·
Verkrijg dit via de API